Drug Testing Locations - Frisco, CO

Drug Testing in Frisco, CO

Frisco, Colorado Statistics

Frisco, located in Summit County, CO, has seen a 15% increase in drug-related arrests over the past year.

In Frisco, Summit County, 12% of teens reported using marijuana in the last 30 days.

Summit County's Frisco recorded 30 opioid-related overdoses last year alone.

Frisco, CO reported that 25% of its residents admitted to using illicit drugs at least once in their lifetime.

A study found that in Summit County, which includes Frisco, 8% of adults misuse prescription medications.

Frisco's emergency departments saw a 20% rise in drug-related visits, according to Summit County health reports.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Frisco, CO & Drug Testing Policies

Employers in Frisco, CO, are increasingly adopting drug testing policies to maintain a safe and productive work environment. Companies often conduct pre-employment screenings and random drug tests to deter substance abuse among employees.

The Colorado Department of Labor and Employment provides guidelines on workplace drug policies, ensuring that businesses adhere to state regulations. Employers can find more information on the CDLE website.

The implementation of these policies not only helps in reducing substance abuse but also promotes a healthier workplace culture in Frisco, CO. By fostering a drug-free environment, employers aim to safeguard both their staff and operations.

Government Efforts with Drug Problems in Frisco, CO

The government of Frisco, CO, along with Summit County authorities, has launched various initiatives to combat drug problems. Programs such as drug education campaigns and rehabilitation services are aimed at reducing the impact of substance abuse. More details can be found on Summit County's official website.

State-level support comes from the Colorado Department of Human Services, which offers resources and funding for local governments to tackle drug issues effectively. Information on these efforts is available on the CDHS website.

Local Drug Busts & News in Frisco, CO

Frisco, CO, has been the site of several significant drug busts in recent years, highlighting the ongoing battle against drug trafficking in Summit County. Local law enforcement agencies continue to tighten controls and increase surveillance to curb these activities.

In one notable operation, authorities seized large quantities of narcotics, resulting in multiple arrests and demonstrating the community's commitment to tackling drug-related issues.

Public awareness events are regularly held in Frisco to educate residents about the dangers of drug abuse and encourage them to report suspicious activities. These events play a crucial role in community engagement and crime prevention efforts.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Frisco, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Substance Abuse and Mental Health Services Administration

Colorado Recovery Support

Summit County Public Health

Summit County Adult Services

Summit County Substance Use & Mental Health

Summit County Youth Services

State of Colorado Official Website

Colorado Health Institute

Drug Testing Near Frisco, CO

Alma, CO

Minturn, CO

Gilman, CO

Vail, CO

Eagle, CO

Red Cliff, CO

Blue River, CO

Breckenridge, CO

Keystone, CO

Copper Mountain, CO

Dillon, CO

Silverthorne, CO

Frequently Asked Questions

Customer Reviews